Neuroprotective effect of solubilized UDCA in focal ischemic model

Details for Australian Patent Application No. 2005279961 (hide)

Owner Yoo, S.

Inventors Yoo, Seo Hong

Agent Pizzeys

Pub. Number AU-B-2005279961

PCT Pub. Number WO2006/026555

Priority 60/605,566 30.08.04 US; 60/629,998 22.11.04 US

Filing date 30 August 2005

Wipo publication date 9 March 2006

Acceptance publication date 13 May 2010

International Classifications

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

A61K 31/718 (2006.01)

A61K 31/723 (2006.01)

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/026555 Priority application(s): WO2006/026555

13 May 2010 Application Accepted

  Published as AU-B-2005279961

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005279964-Whole grain products made with whole grain durum wheat

2005279960-Method of using an implant for treatment of ligaments and tendons